The role of the kidney in the inactivation of injected [125I]kallikrein.
作者信息
Mills I H, Paterson C L, Ward P E
出版信息
J Physiol. 1975 Oct;251(2):281-6. doi: 10.1113/jphysiol.1975.sp011092.
Abstract
摘要
相似文献
1
The role of the kidney in the inactivation of injected [125I]kallikrein.肾脏在注射的[125I]激肽释放酶失活过程中的作用。
J Physiol. 1975 Oct;251(2):281-6. doi: 10.1113/jphysiol.1975.sp011092.
2
The influence of a unilateral nephrectomy on the kallikrein activity of the remaining kidney and on the urinary kallikrein excretion in rats.单侧肾切除对大鼠剩余肾脏激肽释放酶活性及尿激肽释放酶排泄的影响。
Biochem Pharmacol. 1983 May 15;32(10):1657-60. doi: 10.1016/0006-2952(83)90346-5.
3
Interaction of atrial natriuretic peptide and amiloride on renal hemodynamics through renal kallikrein and kinins in anesthetized rabbits.
J Cardiovasc Pharmacol. 1989;13 Suppl 6:S39-42.
4
Clearance and metabolism of glandular kallikrein in the rat.
Am J Physiol. 1985 Jun;248(6 Pt 1):E664-8. doi: 10.1152/ajpendo.1985.248.6.E664.
5
Kallikrein-kinin system and hypertension.
Contrib Nephrol. 1980;23:105-24.
6
The role of kallikrein in the pathogenesis of African trypanosomiasis.激肽释放酶在非洲锥虫病发病机制中的作用。
Adv Biosci. 1978 Jul 22;17:85-92.
7
Urinary and kidney kallikrein in hypertensive rats.高血压大鼠的尿及肾脏激肽释放酶
Biomedicine. 1976 Sep 30;25(7):236-8.
8
9
Effects of thyroid hormones on urinary and renal kallikreins.甲状腺激素对尿和肾激肽释放酶的影响。
Am J Physiol. 1992 Sep;263(3 Pt 1):E430-4. doi: 10.1152/ajpendo.1992.263.3.E430.
10
Kallikrein concentrations in the plasma, lymph, thoracic, and cerebrospinal fluid of rabbits.兔血浆、淋巴液、胸液和脑脊液中的激肽释放酶浓度。
Arch Int Pharmacodyn Ther. 1981 Jul;252(1):162-9.
引用本文的文献
1
Involvement of renal kallikrein in the regulation of bicarbonate excretion in rats.肾激肽释放酶参与大鼠碳酸氢盐排泄的调节。
J Physiol. 1995 Oct 1;488 ( Pt 1)(Pt 1):163-70. doi: 10.1113/jphysiol.1995.sp020954.
2
Enzyme- and immuno-histochemical localization of kallikrein. II. The human kidney.激肽释放酶的酶组织化学和免疫组织化学定位。II. 人肾。
Histochemistry. 1984;80(5):443-8. doi: 10.1007/BF00495432.
3
Abnormal regulation of renal kallikrein in experimental diabetes. Effects of insulin on prokallikrein synthesis and activation.实验性糖尿病中肾激肽释放酶的异常调节。胰岛素对激肽原合成和激活的影响。
J Clin Invest. 1987 Dec;80(6):1651-9. doi: 10.1172/JCI113254.
4
Enhanced contractility of the rat stomach during suppression of angiotensin converting enzyme by captopril in vitro.在体外实验中，卡托普利抑制血管紧张素转换酶时大鼠胃收缩力增强。
Br J Pharmacol. 1991 Apr;102(4):827-30. doi: 10.1111/j.1476-5381.1991.tb12260.x.
本文引用的文献
1
Some effects of glucose and calcium upon the metabolism of kidney slices from adult and newborn rats.葡萄糖和钙对成年及新生大鼠肾切片代谢的某些影响。
Biochem J. 1949;45(1):68-74. doi: 10.1042/bj0450068.
2
BRADYKININ AND FOREARM BLOOD FLOW.缓激肽与前臂血流量
J Physiol. 1964 Apr;170(3):571-81. doi: 10.1113/jphysiol.1964.sp007350.
3
DISTRIBUTION AND METABOLIC FATE OF ANGIOTENSIN II AND VARIOUS DERIVATIVES.血管紧张素II及各种衍生物的分布与代谢归宿
Can Med Assoc J. 1964 Jan 25;90(4):190-3.
4
THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.高比放射性碘-131标记人生长激素的制备
Biochem J. 1963 Oct;89(1):114-23. doi: 10.1042/bj0890114.
5
A vascular permeability factor of renal origin.
Nature. 1963 Jun 15;198:1097-8. doi: 10.1038/1981097a0.
6
Pulmonary extractionof bradykinin and eledoisin.缓激肽和eledoisin的肺提取
Rev Can Biol. 1968 Mar;27(1):75-6.
7
The relationship between kidney and urinary kininogenase.肾脏与尿激肽原酶之间的关系。
Br J Pharmacol. 1970 May;39(1):73-86. doi: 10.1111/j.1476-5381.1970.tb09557.x.
8
A sensitive isotopic procedure for the assay of esterase activity: measurement of human urinary kallikrein.一种用于酯酶活性测定的灵敏同位素方法：人尿激肽释放酶的测量
Clin Chim Acta. 1971 Mar;32(1):67-73. doi: 10.1016/0009-8981(71)90465-7.
9
Increased vascular permeability produced by kallikrein infusions and its enhancement by nephrectomy.激肽释放酶输注引起的血管通透性增加及其通过肾切除术的增强作用。
J Physiol. 1973 May;231(1):45P-47P.
10
Vascular permeability factor: dissociation from the angiotensin II induced pressor and drinking responses.血管通透性因子：与血管紧张素II诱导的升压反应和饮水反应相分离。
Nature. 1973 Mar 30;242(5396):334-5. doi: 10.1038/242334a0.
Zotero 插件